Answers are grounded in this paper and cite their sources.
In this edition of Literature Commentary, Drs. Moster and Gokoffski review the following 4 articles:Maldonado J, Patel B, Ma T, et al. Comprehensive comparison of visual outcomes in macro and giant prolactinoma cohorts managed with medical versus surgical treatment. Neurosurgery. 2026;98(4):826-835. Blockmans D, Penn SK, Setty AR, et al; SELECT-GCA Study Group. A Phase 3 trial of upadacitinib for giant-cell arteritis. N Engl J Med. 2025;392(20):2013-2024. Johannesen KM, Grønskov K, Kessel L, et al. Diagnostic yield and clinical impact of comprehensive WES/WGS testing beyond common genetic causes in hereditary optic atrophy. Clin Genet. 2026;110(3):336-346. Epp SM, Castrillón G, Yuan B, et al. BOLD signal changes can oppose oxygen metabolism across the human cortex. Nat Neurosci. 2026;29:1225-1236.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: